Sugar Land commits to life science
Add Axios as your preferred source to
see more of our stories on Google.
Illustration: Gabriella Turrisi/Axios
Sugar Land is positioning itself to become a life science hub.
Why it matters: The growing suburb southwest of Houston is capitalizing on its proximity to the Texas Medical Center by attracting pharmaceutical manufacturers and biotech firms with lower real estate costs and targeted incentives.
Driving the news: Two life science companies with a presence in Sugar Land are expanding there.
- DeliverIt Group was approved for a $1.3 million incentive this month to build a nearly 60,000-square-foot pharmaceutical manufacturing facility, invest almost $11.9 million and create 55 jobs.
- Hope Biosciences received a $1 million performance-based incentive in January to expand its stem cell manufacturing operations, invest $2 million and add 15 jobs. It was the city's first incentive awarded to a life sciences company.
The big picture: After the pandemic, Sugar Land identified life sciences as one of its newest target industries, building on an existing and expanding healthcare ecosystem, Alba Penate-Johnson, assistant director of economic development at the city, tells Axios.
- Sugar Land has long been a regional hub for industrial manufacturing, engineering and financial services. Officials say expanding the life sciences sector is part of a broader effort to diversify the city's economy.
- The city is home to over a dozen life science companies, including NanoInnovations and Bluebonnet Nutrition.
Zoom in: To attract more firms, Sugar Land revamped its incentive program in 2023 to require at least $1 million in capital investment, a minimum of 10 employees (lowered from the usual 100) and a project agreement that runs five to 10 years
What they're saying: Life science companies are "looking for smaller spaces, a dense medical healthcare hub without having to go into the Texas Medical Center, and to be closer to their workforce," Penate-Johnson says.
Zoom out: Sugar Land's push comes as Greater Houston is also diversifying with life sciences, with major projects, including Eli Lilly's manufacturing facility, coming to the area.
Between the lines: Many healthcare workers already live in Sugar Land and commute to Houston. Penate-Johnson says the city's growing life sciences sector is helping create more opportunities closer to home.